First of two phase I drug-interaction trials of flibanserin in volunteers
Phase of Trial: Phase I
Latest Information Update: 24 Feb 2015
At a glance
- Drugs Flibanserin (Primary)
- Indications Female sexual dysfunction
- Focus Adverse reactions; Registrational
- 24 Feb 2015 Status changed from planning to completed, according to a Sprout Pharmaceuticals media release.
- 17 Feb 2015 Based on data from this trial, a driving study and three pivotal phase III trials, the NDA has been resubmitted to the US FDA, according to a Sprout Pharmaceuticals media release.
- 14 Feb 2014 New trial record